In-Depth IPO Analysis
Detailed reviews of business models, financial health, valuation metrics, peer comparisons, and key risk factors — written in plain language, not jargon.
About IPOroute
IPOroute was built on a simple belief: every investor — retail or institutional — deserves transparent, accurate, and timely IPO data to make confident decisions.
Explore Upcoming IPOs →Our Mission
India's primary market moves fast. IPOroute exists to level the playing field — giving retail investors the same depth of analysis that institutional desks have relied on for years. We aggregate SEBI filings, exchange data, and market sentiment into one easy-to-navigate platform, so you spend less time hunting and more time deciding.
We are not a broker, sub-broker, or investment advisor. We are a data and research platform committed to factual, conflict-free reporting on India's IPO ecosystem.
Informed investors build stronger portfolios. Our job is to make sure you walk into every IPO with your eyes open.
What We Offer
From the moment a DRHP is filed to the day shares list on the exchange, IPOroute covers every stage of the IPO lifecycle.
Detailed reviews of business models, financial health, valuation metrics, peer comparisons, and key risk factors — written in plain language, not jargon.
Live and historical GMP data sourced from unofficial market channels. Understand market sentiment before the listing day even arrives.
Real-time subscription data broken down by category — QIB, NII, and Retail — so you can gauge demand as bidding unfolds.
Check your IPO allotment result instantly using your PAN or application number, with direct links to the official registrar portals.
A complete upcoming IPO schedule with open dates, price bands, lot sizes, and listing dates — organised clearly so you never miss a window.
Stay updated with curated news, DRHP summaries, and regulatory announcements that affect the IPO pipeline and your investments.
Our Principles
These aren't statements on a wall. They define how we source data, write analysis, and evolve our platform.
Every figure on IPOroute traces back to an official source — SEBI filings, BSE/NSE data, or CDSL/NSDL registrar systems. We correct errors publicly and promptly.
IPOroute does not receive commissions from issuers, brokers, or underwriters. Our research independence is non-negotiable and never for sale.
Financial research should be accessible. We write for the curious retail investor, not just chartered accountants or seasoned fund managers.
Markets evolve. So do we. User feedback drives our product roadmap, and we ship updates regularly to keep IPOroute ahead of the market's pace.
Why Investors Choose IPOroute
IPOroute isn't the newest IPO site. It's the one investors come back to because the data is right and the analysis is honest.
No issuer affiliations. No sponsored ratings. Just data and analysis that tells you what you need to know.
GMP, subscription numbers, and allotment results are refreshed continuously during live IPO windows.
Built for how India invests — on a smartphone, between meetings, during subscription deadlines.
We arm you with data and analysis. The investment decision — and responsibility — always stays with you.
IPOroute attracts retail and HNI investors at the exact moment they are researching, comparing, and applying for IPOs — not passive readers, but high-intent decision-makers. Your brand can be part of that moment.
Advertising options
Write to us and we'll share our media kit and rate card.
Editorial independence guaranteed. Advertising partnerships never influence IPOroute's research, GMP data, subscription numbers, or allotment coverage. All sponsored content is clearly labelled as per ASCI guidelines.
IPOroute.com is a financial information and research platform. All content published on this website — including IPO reviews, GMP data, subscription status, and analysis — is strictly for educational and informational purposes only. Nothing on this site constitutes investment advice, a recommendation to buy or sell securities, or an offer of any financial product or service. IPOroute is not registered with SEBI as an investment advisor, research analyst, or stock broker. Investing in IPOs involves risk, including the possible loss of principal. Please consult a SEBI-registered financial advisor before making any investment decision. Past performance and Grey Market Premium figures are not indicative of future listing gains or returns.